[1] |
Pernicova I, Korbonits M. Metformin—mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol, 2014, 10(3):143-156.
doi: 10.1038/nrendo.2013.256
pmid: 24393785
|
[2] |
Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, Molitch ME, Pi-Sunyer X, Darwin C, Heckman-Stoddard BM, Temprosa M, Kahn SE, Nathan DM Diabetes Prevention Program Research Group. Metformin for diabetes prevention: insights gained from the diabetes prevention program/diabetes prevention program outcomes study. Diabetologia, 2017, 60(9):1601-1611.
doi: 10.1007/s00125-017-4361-9
|
[3] |
Flory J, Lipska K. Metformin in 2019. JAMA, 2019, 321(19):1926-1927.
doi: 10.1001/jama.2019.3805
|
[4] |
Hostalek U, Gwilt M, Hildemann S. Therapeutic use of metformin in prediabetes and diabetes prevention. Drugs, 2015, 75(10):1071-1094.
doi: 10.1007/s40265-015-0416-8
pmid: 26059289
|
[5] |
Heckman-Stoddard BM, DeCensi A, Sahasrabuddhe VV, Ford LG. Repurposing metformin for the prevention of cancer and cancer recurrence. Diabetologia, 2017, 60(9):1639-1647.
doi: 10.1007/s00125-017-4372-6
pmid: 28776080
|
[6] |
Wang GX, Xu MQ, Xie MR. Research advance in anti-lung cancer mechanism of metformin. Chinese Journal of Lung Cancer, 2020, 23(4):282-285.
|
|
王高祥, 徐美青, 解明然. 二甲双胍抗肺癌机制研究进展. 中国肺癌杂志, 2020, 23(04):282-285.
|
[7] |
McCreight LJ, Bailey CJ, Pearson ER. Metformin and the gastrointestinal tract. Diabetologia, 2016, 59(3):426-435.
doi: 10.1007/s00125-015-3844-9
pmid: 26780750
|
[8] |
Inzucchi SE, Davies MJ, Khunti K, Trivedi P, George JT, Zwiener I, Johansen OE, Sattar N. Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes. Diabetes Obes Metab, 2021, 23(2):425-433.
doi: 10.1111/dom.14234
pmid: 33084149
|
[9] |
Ouyang J, Isnard S, Lin J, Fombuena B, Peng XR, Chen YK, Routy JP. GDF-15 as a weight watcher for diabetic and non-diabetic people treated with metformin. Front Endocrinol (Lausanne), 2020, 11:581839.
doi: 10.3389/fendo.2020.581839
|
[10] |
Zeng XL, Zhang YF, Tian Q, Xue Y, An RF. Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis. Medicine (Baltimore), 2016, 95(36):e4526.
|
[11] |
Lv ZQ, Guo YJ. Metformin and its benefits for various diseases. Front Endocrinol (Lausanne), 2020, 11:191.
doi: 10.3389/fendo.2020.00191
|
[12] |
Dziedzic A, Saluk-Bijak J, Miller E, Bijak M. Metformin as a potential agent in the treatment of multiple sclerosis. Int J Mol Sci, 2020, 21(17):5957.
doi: 10.3390/ijms21175957
|
[13] |
Chen XY, Guo HF, Qiu L, Zhang CD, Deng Q, Leng QB. Immunomodulatory and antiviral activity of metformin and its potential implications in treating coronavirus disease 2019 and lung injury. Front Immunol, 2020, 11:2056.
doi: 10.3389/fimmu.2020.02056
|
[14] |
柏华, 宋璇婧. 二甲双胍临床应用现状及进展. 临床合理用药杂志, 2019, 12(16):175-177.
|
[15] |
Li N, Felber K, Elks P, Croucher P, Roehl HH. Tracking gene expression during zebrafish osteoblast differentiation. Dev Dyn, 2009, 238(2):459-466.
doi: 10.1002/dvdy.21838
|
[16] |
Fu SQ, Wang ZY, Jiang ZM, Bi ZM, Liu EH. Integration of zebrafish model and network pharmacology to explore possible action mechanisms of morinda officinalis for treating osteoporosis. Chem Biodivers, 2020, 17(5):e2000056.
|
[17] |
Bergen DJM, Kague E, Hammond CL. Zebrafish as an emerging model for osteoporosis: a primary testing platform for screening new osteo-active compounds. Front Endocrinol (Lausanne), 2019, 10:6.
doi: 10.3389/fendo.2019.00006
|
[18] |
Peng W, Zhang WJ, Xue Y. Research progress of zebrafish models of bone diseases. Acta Lab Anim Sci Sin, 2019, 27(2):248-253.
|
|
彭伟, 张文娟, 薛钰. 斑马鱼作为骨骼疾病模型的研究进展. 中国实验动物学报, 2019, 27(2):248-253.
|
[19] |
Zhang WJ, Xu JJ, Qiu JH, Xing CC, Li XM, Leng B, Su Y, Lin JM, Lin JF, Mei XQ, Huang YQ, Pan YT, Xue Y. Novel and rapid osteoporosis model established in zebrafish using high iron stress. Biochem Biophys Res Commun, 2018, 496(2):654-660.
doi: 10.1016/j.bbrc.2017.12.172
|
[20] |
Xu JJ, Zhang WJ, Wang JY, Yao LY, Pan YT, Ou YX, Xue Y. The active component screening of Anoectochilus roxburghii and the functional study on inhibition of melanogenesis in zebrafish. Hereditas (Beijing), 2017, 39(12):1178-1187.
|
|
许璟瑾, 张文娟, 王静怡, 姚丽云, 潘裕添, 欧一新, 薛钰. 金线莲抑制斑马鱼黑色素形成的活性组分筛选及机理研究. 遗传, 2017, 39(12):1178-1187.
|
[21] |
Aceto J, Nourizadeh-Lillabadi R, Bradamante S, Maier JA, Alestrom P, van Loon JJ, Muller M. Effects of microgravity simulation on zebrafish transcriptomes and bone physiology- exposure starting at 5 days post fertilization. NPJ Microgravity, 2016, 2:16010.
doi: 10.1038/npjmgrav.2016.10
|
[22] |
Huo L, Wang L, Yang ZY, Li PY, Geng DC, Xu YZ,. Prednisolone induces osteoporosis-like phenotypes via focal adhesion signaling pathway in zebrafish larvae. Biol Open, 2018, 7(7): bio029405.
doi: 10.1242/bio.029405
|
[23] |
Huang HX, Lin H, Lan F, Wu YF, Yang ZG, Zhang JJ. Application of bone transgenic zebrafish in anti-osteoporosis chemical screening. Animal Model Exp Med, 2018, 1(1):53-61.
doi: 10.1002/(ISSN)2576-2095
|
[24] |
Xue Y. Organizer-drived Bmp signal is required for zebrafish embryonic dorsoventral pattering[Dissertation]. Tsinghua University, 2014.
|
|
薛钰. 斑马鱼胚胎组织中心表达的Bmp信号在背腹分化中的作用[学位论文]. 清华大学, 2014.
|
[25] |
Yang J, Tong GX, Zhang XH, Sun ZP, Lv WH, Sun XW, Kuang YY. Comparative analysis of embryonic muscle development in wildtype zebrafish and its intermuscular bone deficiency mutant. J Fish Sci Chin, 2019, 26(2):296-303.
|
|
杨建, 佟广香, 郑先虎, 孙志鹏, 吕伟华, 孙效文, 匡友谊. 肌间刺缺失突变对斑马鱼胚胎发育过程中肌肉发育的影响. 中国水产科学, 2019, 26(2):296-303.
|
[26] |
Chen SJ, Guo FJ. Progress research on mechanism of chondrogenic promotion by Sox9 gene. Int J Orthop, 2010, 31(2):65-67.
|
|
陈少坚, 郭风劲. Sox9基因促软骨形成作用机制研究进展. 国际骨科学杂志, 2010, 31(2):65-67.
|
[27] |
Lin ZW, Yang F, Huang TY, Chen TT, Cui J, Li MY, Hua YQ. Study on the anti-osteoporosis effect of paeoniflorin on osteoblast apoptosis and zebrafish osteoporosis model. J Nanjing Univ Tradit Chin Med, 2019, 35(4):426-431.
|
|
林紫微, 杨菲, 黄天一, 陈婷婷, 崔杰, 李梦雨, 华永庆. 芍药苷干预成骨细胞凋亡抗骨质疏松作用研究. 南京中医药大学学报, 2019, 35(4):426-431.
|
[28] |
Wan M, Cao X. BMP signaling in skeletal development. Biochem Biophys Res Commun, 2005, 328(3):651-657.
doi: 10.1016/j.bbrc.2004.11.067
|
[29] |
Singh SP, Holdway JE, Poss KD. Regeneration of amputated zebrafish fin rays from de novo osteoblasts. Dev Cell, 2012, 22(4):879-886.
doi: 10.1016/j.devcel.2012.03.006
|
[30] |
Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, Haffner SM, Hoskin M, Nathan DM; Diabetes Prevention Program Research Group. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab, 2008, 4(7):382-93.
doi: 10.1038/ncpendmet0843
pmid: 18493227
|
[31] |
Lecka-Czernik B. Safety of anti-diabetic therapies on bone. Clin Rev Bone Miner Metab, 2013, 11(1):49-58.
pmid: 23543908
|